Search Results 451-460 of 15277 for Uvetils
The purpose of this study is to use a simplified lung assessment which could offer patients a novel, convenient and non-invasive evaluation of the actual status ...
The random assignment in this study is "1 to 1" which means that participants have an equal chance of receiving belimumab or placebo. Participation eligibility.
The purpose of this study is to understand patient interest in use of wearable technology for monitoring health, assess patient willingness to use wearable ...
About this study. The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study · To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.
About this study. This is a Phase Ib, open-label, multicenter, global study designed to assess the safety and tolerability of RO6870810 as monotherapy and ...
Each study participant will receive a Brain Activity Sensing Headband system with an APP, wearable activity tracking device, and earbuds to participate in the ...
This randomized study will compare a personalized Survivorship Care Plan (SCP) template with usual care (no SCP). The investigators hypothesize that the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.